Jeffrey Chodakewitz, EVP GMDA, CMO at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 4,692 shares at $167.44 ($782K) on 2018-02-01, disclosed to the SEC on 2018-02-05.
Seasonal sale ($782k) by EVP GMDA, CMO — this insider has traded VRTX in February in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $167.44 | 1,900 | $318K | 40.7% |
| 2 | $165.23 | 600 | $99K | 12.7% |
| 3 | $166.10 | 996 | $165K | 21.2% |
| 4 | $166.10 | 996 | $165K | 21.2% |
| 5 | $168.06 | 100 | $17K | 2.1% |
| 6 | $169.49 | 100 |
| $17K |
| 2.2% |
| Total | $166.65 avg | 4,692 | $782K | 100% |
| Filing → |
| VRTX | SELL | 2018-01-17 | $351K | — | Filing → |
| VRTX | SELL | 2018-01-03 | $756K | — | Filing → |
| VRTX | SELL | 2017-11-06 | $1.5M | — | Filing → |